Trials / Completed
CompletedNCT01614691
Safety and Efficacy of SPARC1203 in Allergic Rhinitis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 159 (actual)
- Sponsor
- Sun Pharma Advanced Research Company Limited · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study will assess safety and efficacy of SPARC1203 delivered via nasal spray in patients with allergic rhinitis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SPARC1203 | Active |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2012-06-01
- Primary completion
- 2012-11-01
- Completion
- 2013-03-01
- First posted
- 2012-06-08
- Last updated
- 2019-05-03
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01614691. Inclusion in this directory is not an endorsement.